126 related articles for article (PubMed ID: 38631604)
1. Targeted plasma proteomic analysis uncovers a high-performance biomarker panel for early diagnosis of gastric cancer.
Feng T; Jie M; Deng K; Yang J; Jiang H
Clin Chim Acta; 2024 May; 558():119675. PubMed ID: 38631604
[TBL] [Abstract][Full Text] [Related]
2. A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer.
Shen Q; Polom K; Williams C; de Oliveira FMS; Guergova-Kuras M; Lisacek F; Karlsson NG; Roviello F; Kamali-Moghaddam M
EBioMedicine; 2019 Jun; 44():322-333. PubMed ID: 31151932
[TBL] [Abstract][Full Text] [Related]
3. Novel urinary protein biomarker panel for early diagnosis of gastric cancer.
Shimura T; Dayde D; Wang H; Okuda Y; Iwasaki H; Ebi M; Kitagawa M; Yamada T; Yamada T; Hanash SM; Taguchi A; Kataoka H
Br J Cancer; 2020 Nov; 123(11):1656-1664. PubMed ID: 32934343
[TBL] [Abstract][Full Text] [Related]
4. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer.
Roy S; Kanda M; Nomura S; Zhu Z; Toiyama Y; Taketomi A; Goldenring J; Baba H; Kodera Y; Goel A
Mol Cancer; 2022 Feb; 21(1):42. PubMed ID: 35139874
[TBL] [Abstract][Full Text] [Related]
6. Urine proteomic signatures predicting the progression from premalignancy to malignant gastric cancer.
Fan H; Li X; Li ZW; Zheng NR; Cao LH; Liu ZC; Liu MW; Li K; Wu WH; Li ZX; Zhou T; Zhang Y; Liu WD; Zhang LF; You WC; Wang Y; Wu J; Pan KF; Qin J; Li WQ
EBioMedicine; 2022 Dec; 86():104340. PubMed ID: 36356476
[TBL] [Abstract][Full Text] [Related]
7. A novel urinary microRNA biomarker panel for detecting gastric cancer.
Iwasaki H; Shimura T; Yamada T; Okuda Y; Natsume M; Kitagawa M; Horike SI; Kataoka H
J Gastroenterol; 2019 Dec; 54(12):1061-1069. PubMed ID: 31240436
[TBL] [Abstract][Full Text] [Related]
8. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer.
Zhu C; Ren C; Han J; Ding Y; Du J; Dai N; Dai J; Ma H; Hu Z; Shen H; Xu Y; Jin G
Br J Cancer; 2014 Apr; 110(9):2291-9. PubMed ID: 24595006
[TBL] [Abstract][Full Text] [Related]
9. NAD(P)-dependent steroid dehydrogenase-like protein and neutral cholesterol ester hydrolase 1 serve as novel markers for early detection of gastric cancer identified using quantitative proteomics.
Xiao Y; Xie J; Liu L; Huang W; Han Q; Qin J; Liu S; Jiang Z
J Clin Lab Anal; 2021 Feb; 35(2):e23652. PubMed ID: 33219617
[TBL] [Abstract][Full Text] [Related]
10. A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.
Guo X; Peng Y; Song Q; Wei J; Wang X; Ru Y; Xu S; Cheng X; Li X; Wu D; Chen L; Wei B; Lv X; Ji G
Gastroenterology; 2023 Aug; 165(2):402-413.e13. PubMed ID: 36894035
[TBL] [Abstract][Full Text] [Related]
11. A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer.
Lee IS; Ahn J; Kim K; Okugawa Y; Toiyama Y; Hur H; Goel A
Br J Cancer; 2021 Sep; 125(6):846-853. PubMed ID: 34163003
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the Diagnostic Efficiency of a Liquid Biopsy Assay for Early Detection of Gastric Cancer.
Izumi D; Zhu Z; Chen Y; Toden S; Huo X; Kanda M; Ishimoto T; Gu D; Tan M; Kodera Y; Baba H; Li W; Chen J; Wang X; Goel A
JAMA Netw Open; 2021 Aug; 4(8):e2121129. PubMed ID: 34427680
[TBL] [Abstract][Full Text] [Related]
13. Multiple cytokine profiling in serum for early detection of gastric cancer.
Li J; Xu L; Run ZC; Feng W; Liu W; Zhang PJ; Li Z
World J Gastroenterol; 2018 Jun; 24(21):2269-2278. PubMed ID: 29881236
[TBL] [Abstract][Full Text] [Related]
14. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M
BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476
[TBL] [Abstract][Full Text] [Related]
15. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
[TBL] [Abstract][Full Text] [Related]
16. A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer.
Chung HW; Kim JJ; Choi JI; Lee HR; Lim JB
Yonsei Med J; 2019 Aug; 60(8):713-719. PubMed ID: 31347325
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of Plasma Metabolomic Signatures in Precancerous Gastric Lesions That Progress to Cancer.
Huang S; Guo Y; Li ZW; Shui G; Tian H; Li BW; Kadeerhan G; Li ZX; Li X; Zhang Y; Zhou T; You WC; Pan KF; Li WQ
JAMA Netw Open; 2021 Jun; 4(6):e2114186. PubMed ID: 34156450
[TBL] [Abstract][Full Text] [Related]
18. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
19. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer.
Zhou X; Yin C; Dang Y; Ye F; Zhang G
Sci Rep; 2015 Jun; 5():11516. PubMed ID: 26096073
[TBL] [Abstract][Full Text] [Related]
20. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer.
Song MY; Pan KF; Su HJ; Zhang L; Ma JL; Li JY; Yuasa Y; Kang D; Kim YS; You WC
PLoS One; 2012; 7(3):e33608. PubMed ID: 22432036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]